A case of cerebral aneurysmal subarachnoid hemorrhage in Fabry's disease

Journal of Korean Neurosurgical Society

Volumn 53, Issue 3, 2013, Pages 187-189

  Chang, Youn Hyuk ^a   Hwang, Sung Kyun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Cerebral aneurysm; Fabry's diseas; Subarachnoid hemorrhage

Indexed keywords

ADULT; ARTICLE; BRAIN ARTERY ANEURYSM; CLINICAL ARTICLE; COIL EMBOLIZATION; FABRY DISEASE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; NEPHROSIALIDOSIS; POSTERIOR COMMUNICATING ARTERY; POSTOPERATIVE PERIOD; PROTEINURIA; SACCULAR ANEURYSM; SUBARACHNOID HEMORRHAGE; URINALYSIS;

EID: 84876756196     PISSN: 20053711     EISSN: 15987876     Source Type: Journal    
DOI: 10.3340/jkns.2013.53.3.187     Document Type: Article

References (17)

1. Baptista MV, Ferreira S, Pinho-E-Melo T, Carvalho M, Cruz VT, Carmona C, et al.: Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study-screening genetic conditions in Portuguese young stroke patients. Stroke 41: 431-436, 2010
2. Brady RO, Schiffmann R: Clinical features of and recent advances in therapy for Fabry disease. JAMA 284: 2771-2775, 2000
3. Brouns R, Sheorajpanday R, Braxel E, Eyskens F, Baker R, Hughes D, et al.: Middelheim Fabry Study (MiFaS): a retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke. Clin Neurol Neurosurg 109: 479-484, 2007
4. Brouns R, Thijs V, Eyskens F, Van den Broeck M, Belachew S, Van Broeckhoven C, et al.: Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke 41: 863-868, 2010
5. Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, et al.: Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50: 1746-1749, 1998
6. Dobrovolny R, Dvorakova L, Ledvinova J, Magage S, Bultas J, Lubanda JC, et al.: Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med (Berl) 83: 647-654, 2005
7. Fabry H: An historical overview of Fabry disease. J Inherit Metab Dis 24 Suppl 2: 3-7, 2001
8. Fellgiebel A, Keller I, Marin D, Müller MJ, Schermuly I, Yakushev I, et al.: Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology 72: 63-68, 2009
9. Fellgiebel A, Müller MJ, Ginsberg L: CNS manifestations of Fabry's disease. Lancet Neurol 5: 791-795, 2006
10. MacDermot KD, Holmes A, Miners AH: Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38: 769-775, 2001
11. Mehta A, Ricci R, Widmer U, Dehout F, Garciade Lorenzo AKampmann C et al.: Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34: 236-242, 2004
12. Møller AT, Jensen TS: Neurological manifestations in Fabry's disease. Nat Clin Pract Neurol 3: 95-106, 2007
13. Nakamura K, Sekijima Y, Nakamura K, Hattori K, Nagamatsu K, Shimizu Y, et al.: Cerebral hemorrhage in Fabry's disease. J Hum Genet 55: 259-261, 2010
14. Reisin RC, Romero C, Marchesoni C, Nápoli G, Kisinovsky I, Cáceres G, et al.: Brain MRI findings in patients with Fabry disease. J Neurol Sci 305: 41-44, 2011
15. Rolfs A, Böttcher T, Zschiesche M, Morris P, Winchester BBauer Pet al, Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 366: 1794-1796, 2005
16. Sims K, Politei J, Banikazemi M, Lee P: Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry. Stroke 40: 788-794, 2009
17. Zarate YA, Hopkin RJ: Fabry's disease. Lancet 372: 1427-1435, 2008